These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
717 related articles for article (PubMed ID: 21889825)
21. Macrocyclic Compounds: Emerging Opportunities for Current Drug Discovery. You L; An R; Liang K; Cui B; Wang X Curr Pharm Des; 2016; 22(26):4086-93. PubMed ID: 26845327 [TBL] [Abstract][Full Text] [Related]
25. New approaches for studying the chemical diversity of natural resources and the bioactivity of their constituents. Wolfender JL; Queiroz EF Chimia (Aarau); 2012; 66(5):324-9. PubMed ID: 22867545 [TBL] [Abstract][Full Text] [Related]
26. Therapeutic applications of compounds in the Magnolia family. Lee YJ; Lee YM; Lee CK; Jung JK; Han SB; Hong JT Pharmacol Ther; 2011 May; 130(2):157-76. PubMed ID: 21277893 [TBL] [Abstract][Full Text] [Related]
28. [Review of bioactivities of natural cycloartane triterpenoids]. Tian Z; Xiao PG; Wen J; Huang F; Yang MS; Chen SL Zhongguo Zhong Yao Za Zhi; 2006 Apr; 31(8):625-9. PubMed ID: 16830816 [TBL] [Abstract][Full Text] [Related]
29. New aspects of natural products in drug discovery. Lam KS Trends Microbiol; 2007 Jun; 15(6):279-89. PubMed ID: 17433686 [TBL] [Abstract][Full Text] [Related]
30. Chemical constituents of plants from the genus Buxus. Zhang J; Qin XY; Zhang SD; Xu XS; Pei JP; Fu JJ Chem Biodivers; 2015 Sep; 12(9):1289-306. PubMed ID: 26363874 [No Abstract] [Full Text] [Related]
31. The impact of plant-pathogen studies on medicinal drug discovery. Ottmann C; van der Hoorn RA; Kaiser M Chem Soc Rev; 2012 Apr; 41(8):3168-78. PubMed ID: 22293617 [TBL] [Abstract][Full Text] [Related]
32. Traditional Australian Aboriginal medicinal plants: an untapped resource for novel therapeutic compounds? Locher C; Semple SJ; Simpson BS Future Med Chem; 2013 May; 5(7):733-6. PubMed ID: 23651086 [No Abstract] [Full Text] [Related]
33. Plants as a source of therapeutic and health products. Christen P; Cuendet M Chimia (Aarau); 2012; 66(5):320-3. PubMed ID: 22867544 [TBL] [Abstract][Full Text] [Related]
34. Plant derived secondary metabolites as anti-cancer agents. Rawat DS; Singh R Anticancer Agents Med Chem; 2013 Dec; 13(10):1551. PubMed ID: 24341389 [No Abstract] [Full Text] [Related]
35. Angelica keiskei, an emerging medicinal herb with various bioactive constituents and biological activities. Kil YS; Pham ST; Seo EK; Jafari M Arch Pharm Res; 2017 Jun; 40(6):655-675. PubMed ID: 28439780 [TBL] [Abstract][Full Text] [Related]
36. Chemical composition and biological activity of the essential oil obtained from Bupleurum marginatum (Apiaceae). Ashour ML; El-Readi M; Youns M; Mulyaningsih S; Sporer F; Efferth T; Wink M J Pharm Pharmacol; 2009 Aug; 61(8):1079-87. PubMed ID: 19703352 [TBL] [Abstract][Full Text] [Related]
37. In vitro cytotoxic, antiprotozoal and antimicrobial activities of medicinal plants from Vanuatu. Bradacs G; Maes L; Heilmann J Phytother Res; 2010 Jun; 24(6):800-9. PubMed ID: 20014163 [TBL] [Abstract][Full Text] [Related]
38. Antiplasmodial, anti-inflammatory and cytotoxic activities of various plant extracts from the Mascarene Archipelago. Jonville MC; Kodja H; Strasberg D; Pichette A; Ollivier E; Frédérich M; Angenot L; Legault J J Ethnopharmacol; 2011 Jul; 136(3):525-31. PubMed ID: 20600776 [TBL] [Abstract][Full Text] [Related]
39. Elicitation, a new window into plant chemodiversity and phytochemical drug discovery. Poulev A; O'Neal JM; Logendra S; Pouleva RB; Timeva V; Garvey AS; Gleba D; Jenkins IS; Halpern BT; Kneer R; Cragg GM; Raskin I J Med Chem; 2003 Jun; 46(12):2542-7. PubMed ID: 12773057 [TBL] [Abstract][Full Text] [Related]